Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 94956
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.94956
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.94956
Table 1 Patient characteristics, n (%)
| Variable | n | mean ± SD |
| Age (years) | 58 ± 12.836 | |
| BMI | 22.10 ± 3.692 | |
| Sex | ||
| Male | 48 (38.70) | |
| Female | 76 (61.30) | |
| Anatomic site of GIST | ||
| Gastric tumors | 76 (61.30) | |
| Non-gastric tumors | 48 (38.70) | |
| Tumor size (cm) | ||
| < 5 | 66 (53.23) | |
| ≥ 5 | 58 (46.77) | |
| Targeted therapy | ||
| Yes | 31 (25) | |
| No | 93 (75) | |
| 5-years RFS | 93 (75) |
- Citation: Zhao JL, Wang MY, Lv YZ, Zhou YJ. Prognostic value of inflammatory markers in predicting recurrence-free survival in gastrointestinal stromal tumor patients: A nomogram-based approach. World J Gastrointest Oncol 2025; 17(2): 94956
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/94956.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.94956